Hogild et al. have found that GH signaling is normal in obesity and there is increased hepatic GH sensitivity, suggesting that the blunted GH levels in obesity may protect against insulin resistance without compromising IGF-1 levels [54]. This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.